SDI Strategic Diagnostics, Inc. - Dedicated to the discovery, development and commercialization of antibody based solutions

Strategic Diagnostics Announces Stanley Fronczkowski to Step Down as Chief Financial Officer
Strategic Diagnostics Reports Third Quarter 2008 Results, Significant Growth Seen in Key Segments: Genomic Antibody Technology™ Revenue Grows 191% - Food Pathogens Revenue Grows 38% - Water and Environmental Product Revenue Grow 14% Year over Year
Strategic Diagnostics Inc. Announces Partnership with the University of Delaware and the Helen F. Graham Cancer Center to Develop Cancer Assays
Strategic Diagnostics to Report Third Quarter Results on October 30, 2008
Strategic Diagnostics Appoints Deborah Day Barbara as Vice President of Business Development
Strategic Diagnostics Inc. Approves Stock Repurchase Program
Strategic Diagnostics Appoints Fran DiNuzzo as President & Chief Executive Officer
Strategic Diagnostics Reports Second Quarter Results
Strategic Diagnostics Inc. to Produce Library of Antibodies for the Study of Usher Syndrome
Strategic Diagnostics Announces Executive Management Changes
Strategic Diagnostics Inc. Enters Supply Agreement for Antibody Library for Study of Chromosome Proteins with University of North Carolina Chapel Hill
Strategic Diagnostics Reports First Quarter 2008 Results
SDI Announces Earth Day Sale of Microtox® Platform to China
Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research
Strategic Diagnostics to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference April 3
Strategic Diagnostics Announces New Board Appointments
Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
Strategic Diagnostics Announces the Commercial Introduction of 3 New Test Methods for Agricultural Product Testing, Test Strips Developed for the Detection of Aflatoxin, Cry34Ab1 and a Dual-Trait Cry1F/Cry34Ab1 in Corn.

Check out our latest products

SDI's proprietary Genomic Antibody Technology™ provides you with custom antibodies in less than 76 days. Learn more

An antibody catalog featuring over 600 antibodies, many oncology-focused antibodies. Learn more

The RapidChek® SELECT™ System offers patent pending, cost-effective tests for the detection of Salmonella in food and environmental samples.
Learn more

About Strategic Diagnostics Inc.

Strategic Diagnostics Inc. (SDI) is the largest custom antibody producer in the United States. We provide custom monoclonal antibody, custom polyclonal antibody, and contract assay development services for the pharmaceutical, diagnostic, biotechnology, academic, and OEM markets.

We are a leading developer and manufacturer of immunoassay-based test kits for both field testing and laboratory use. These products are used extensively for:

Food safety, such as salmonella test kits, e. coli test kits, and listeria test kits.
Environmental assessment, environmental testing and remediation.
Water quality testing and toxicity testing.
GMO test for grain, seed and feed.

© 2008 Strategic Diagnostics Inc.
111 Pencader Drive, Newark DE 19702-3322 USA
Sales: (800) 544-8881 Tel: (302) 456-6789 Fax: (302) 456-6782